Peter O'Donnell, ACT's Brussels Correspondent
Advertisement
Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.
Articles by Peter O'Donnell, ACT's Brussels Correspondent
Findings show big pharma increasingly turning to other companies for molecules to stock its pipeline.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
2
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
3
How Sourcing Decisions Shape Site Experience and Study Execution
4
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
5